ADPT
#1503
Adaptive Biotechnologies Corporation - Common Stock
25.3 8 USD
-0.04%
Market Price
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
-4.01%
Variación mensual
+12.90%
Variación en los últimos 6 meses
+63.64%
Cambio anual
+47.05%
Cierres anteriores
26.4 4
Open
25.3 6
Mínimo
25.1 7
Máximo
25.5 0
Volumen
440
Financials
- Market Capitalization 4.05 B
- Employee 624
- Founded 2009
- CEO Chad Robins
- Website www.adaptivebiotech.com
- Headquarter Washington, United States
- FIGI BBG001J2PFF5
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-41.64
Relación precio/flujo de caja
8.9
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 1462 |  ELVN Enliven Therapeutics, Inc. - Common Stock | 58.48 USD | -3.34% | -1.47% | +8.32% | +183.06% | 4.28 B USD | ||
| 1497 |  RLAY Relay Therapeutics, Inc. - Common Stock | 18.67 USD | -3.86% | -3.61% | +0.92% | +401.88% | 4.09 B USD | ||
| 1508 |  TNGX Tango Therapeutics, Inc. - Common Stock | 23.76 USD | -6.01% | -0.71% | -11.41% | +246.86% | 4.01 B USD | ||
| 1518 |  AMLX Amylyx Pharmaceuticals, Inc. - Common Stock | 35.49 USD | -4.55% | -8.37% | +82.00% | +275.56% | 3.95 B USD |